Your browser doesn't support javascript.
loading
Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway.
El-Shamarka, Marwa El-Sayed; El-Sahar, Ayman E; Saad, Muhammed A; Assaf, Naglaa; Sayed, Rabab H.
Afiliação
  • El-Shamarka ME; Department of Narcotics, Ergogenic Aids and Poisons, National Research Center, Cairo, Egypt.
  • El-Sahar AE; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Egypt.
  • Saad MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Egypt; School of Pharmacy, Newgiza University, Cairo, Egypt. Electronic address: Mohammed.abdellatif@pharma.cu.edu.eg.
  • Assaf N; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Misr University for Science and Technology, Cairo, Egypt.
  • Sayed RH; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Egypt.
Life Sci ; 300: 120569, 2022 Jul 01.
Article em En | MEDLINE | ID: mdl-35472453
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Huntington / Fármacos Neuroprotetores / Doenças Neurodegenerativas Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Revista: Life Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Huntington / Fármacos Neuroprotetores / Doenças Neurodegenerativas Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Revista: Life Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito